There is the Knife, a sharp, narrowing price sequence.
Theorem 2.5 Let { X n, n ≥ 1 } be an m stock relative price sequence and a ∗-mixing sequence.
Corollary 2.9 Let { X n, n ≥ 1 } be the m stock relative price sequence and be the ∗-mixing sequence.
The first step is to generate the relative price data { x n = c n + 1 c n, n ≥ 1 }, which are a realization of the relative price sequence { X n = C n + 1 C n, n ≥ 1 }.
In this paper, we suppose the relative price sequence satisfying the ∗-mixing condition, which means that the relative stock prices in two periods gradually become independent when the interval between two periods is longer and longer.
Lemma 2.2 Let { X n, n ≥ 1 } be the m-dimension stock relative price sequence as given above and { b n, n ≥ 1 } be the m-dimension investment strategy sequence as given above.
Specifically, suppose the relative price sequence data { x n } contain M data, i.e., our sequence data are { x n, 1 ≤ n ≤ M }, x M is the most recent datum.
Although the decreasing price of sequencing may soon make genome sequencing more attractive, the additional costs of data handling and downstream analysis cannot be ignored.
We chose only one of the original Illumina TruSeq-generated exomes because we wanted to provide a standard use case scenario for someone who wishes to perform NGS analysis, and while whole genome sequencing is continuing to drop in price, exome sequencing is still a popular and viable alternative [ 1].
Despite the decrease in the price of sequencing itself, the cost and time for preparation of sequencing libraries limit the affordability and feasibility of sequencing large numbers of genomes.
On top, third generation sequencing promises to deliver a further speed-up, reducing the time and price for sequencing a human genome from weeks to days and from thousands to under a hundred USD, respectively [ 2].
